Infectious Disease Diagnostics Market Size | Global Report 2028

Infectious Disease Diagnostics Market Forecast to 2028- COVID-19 Impact, and Global Analysis - by Product (Kits and Reagents, Instruments, and Software and Service  ss), Disease Indication [HIV, Hepatitis, Healthcare- Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and Others Disease Indications  ], Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and, Point of Care Testing), End User (Hospitals and Clinics, Pathology or Diagnostic Laboratories, Research Institutes, Home-Care Settings, and Others End User), and Geography

Publication Month: Apr 2022 | Report Code: TIPHE100001430 | No. of Pages: 226 | Category: Biotechnology | Status: Published

The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028

Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organisms. Infectious disease diagnostics are the methods hospitals and clinical laboratories use to detect or identify foreign antigens/organisms by using several diagnostic tests. These tests assist in identifying the type of pathogen and the extent of the degree to which the disease is spread in the body. The diagnostic procedure is performed with the aid of conventional diagnostic tests or point-of-care testing tools.

The infectious disease diagnostics market is segmented on the basis of product, disease indication, technology, testing type, end user, and geography. By geography, the infectious disease diagnostics market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The infectious disease diagnostics market report offers insights and in-depth analysis of the market, emphasizing parameters such as market size, trends, technological advancements, and market dynamics, and the analysis of the competitive landscape of the globally leading market players.

The growth of the infectious disease diagnostics market is attributed to growing awareness for early disease diagnosis, a shift in focus from centralized laboratories to decentralized POC testing, and rising technological advancements. However, the high cost associated with diagnostic instruments restricts the market growth.

Strategic Insights

Lucrative Regions in Infectious Disease Diagnostics Market

Lucrative Regions in Infectious Disease Diagnostics Market

Get more information on this report :


Market Insights

Rising Prevalence of Infectious Diseases

Infectious diseases are caused by infectious agents, such as viruses, bacteria, parasites, fungi, and toxic products. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), ~ 37.7 million people had HIV in 2020. Out of these, 1.7 million were children aged 0–14 years, and 36 million were adults. Also, more than half (53%) were girls and women. 1.5 million new HIV cases were reported in 2020 globally. Similarly, hepatitis is inflammation of the liver caused by a viral infection. The five main strains of hepatitis viruses are A, B, C, D, and E. According to World Health Organization (WHO), around 58 million people across the globe have chronic hepatitis C virus infection, and ~1.5 million new infections occur every year.

According to World Health Organization (WHO) tuberculosis (TB) is the 13th top cause of death globally and the second leading infectious disease after COVID-19. According to the WHO, there were 1.5 million deaths caused by TB in 2020 (including 214,000 people affected by HIV). In 2020, WHO projected that 10 million people had TB globally, including 1.1 million children, 3.3 million women, and 5.6 million men. TB is present in all age groups and countries. Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Diagnostics play an essential role in determining the direction of any medical treatment of infectious diseases. Therefore, the rising prevalence of infectious diseases across the globe propels the growth of the infectious disease diagnostics market.

Product-Based Insights

Based on product, the global infectious disease diagnostics market , based on product, has beenis segmented into kits and reagents, instruments, and software and services . In 2021, the kits and reagents held the largest share of the market, by product. However, the software and services segment are is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028.

Infectious Disease Diagnostics Market, by Product – 2021 and 2028

Infectious Disease Diagnostics Market, by Product – 2021 and 2028

Get more information on this report :


Disease Indication-Based Insights

Based on disease indication, the global infectious disease diagnostics market , based on disease indication, is segmented into HIV, hepatitis, healthcare- associated infections (HAIs), human papillomavirus (HPV), tuberculosis (TB), influenza, and others disease indications. The hepatitis segment held the largest share of the market in 2021. However, the healthcare- associated infections (HAIs) segment is anticipated to register the highest CAGR during the forecast period.

Technology-Based Insights

Based on technology, the global infectious disease diagnostics market , based on technology, has beenis segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. In 2021, the immunodiagnostics segment held the largest share of the market, by technology. However, the next generation sequencing segment is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028.

Testing Type-Based Insights

Based on testing type, the global infectious disease diagnostics market, based on testing type, has been is segmented bifurcated into laboratory testing and point of- care testing immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. In 2021, the immunodiagnostics laboratory testing segment held the largest share of the market, by testing type. However, the next generation sequencingpoint -of -care testing segment is expected to witness growth in its demand at a fastest CAGR during 2021 to 2028.

End User-Based Insights

Based on end user, the global infectious disease diagnostics market is, based on end user, has been segmented into hospitals & clinics, pathology or diagnostic laboratories, research institutes, home care settings, and others. In 2021, the pathology or diagnostic laboratories segment held the largest share of the market, by end user. However, the home care settings segment is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028.

Several companies adopt strategies, such as product launches and approvals, to expand their global footprints and product portfolios. Moreover, the infectious disease diagnostics market players focus on the partnership strategy to enlarge their clientele, which permits them to maintain their brand name globally. The market share is anticipated to flourish with the development of new innovative products by market players. Danaher; Abbott; BD; Trinity Biotech; F. HOFFMANN-LA ROCHE LTD.; Cardinal Health Inc.; bioMerieux SA; BIO-RAD LABORATORIES INC.; AccuBioTech Co., Ltd.; and ACON Laboratories, Inc. are among the leading companies operating in the global infectious disease diagnostics market.

Frequently Asked Questions

Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organism species. Infectious disease diagnostics are the methods utilized by hospitals, clinical laboratories, and others to detect or identify foreign antigens/organisms by using several diagnostic tests. These tests assist in the identification of the kind of pathogen. Also, the level of the degree to which the disease is spread in the body. The diagnostic procedure may be sent with the aid of conventional diagnostic tests or point-of-care testing tools.
The factors that are driving and restraining factors that will affect the infectious disease diagnostics market in the coming years Growth of the global infectious disease diagnostic market is majorly driven by increase in prevalence of infectious disease such as hepatitis, influenza, COVID-19, & human immuno deficiency virus (HIV); rise in demand for point-of-care diagnostic test; increase in funding from private & government organizations for diagnostic service centers; and advancements in technologies in the field of infectious disease diagnostics. However, lack of reimbursement policy is likely to hinder the market growth.
The infectious disease diagnostics market majorly consists of the players such as F.Hoffmann-La Roche, Ltd.; Danaher Corporation; BD; bioMérieux SA; AccuBioTech Co., Ltd.; Bio-Rad Laboratories, Inc.; ACON Laboratories, Inc.; Abbott; Trinity Biotech; and Cardinal Health, Inc. amongst others.
The infectious disease diagnostics market, by disease indication, is bifurcated into HIV, hepatitis, healthcare associated infections (HAIS), human papillomavirus (HPV), tuberculosis (TB), influenza, and other disease indications.. In 2021, the hepatitis segment held the largest share of the market, by disease indication. However, the healthcare associated infections (HAIS) segment is expected to witness growth in its demand at a fastest CAGR during the forecast period 2021 to 2028.

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Infectious Disease Diagnostics Market – By Product

1.3.2 Global Infectious Disease Diagnostics Market – By Technology

1.3.3 Global Infectious Disease Diagnostics Market – By Testing Type

1.3.4 Global Infectious Disease Diagnostics Market – By Disease Indication

1.3.5 Global Infectious Disease Diagnostics Market – By End User

1.3.6 Global Infectious Disease Diagnostics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Infectious Disease Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Infectious Disease Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Infectious Disease

5.1.2 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Growing Opportunities in Developing Nations

5.4 Future Trend

5.4.1 Rising Number of Product Approvals and Launches

5.5 Impact Analysis

6. Infectious Disease Diagnostics Market– Global Analysis

6.1 Global Infectious Disease Diagnostics Market Revenue Forecast and Analysis

6.1.1 Global Infectious Disease Diagnostics Market Revenue Forecast and Analysis

6.1.2 Global Infectious Disease Diagnostics Market – Market Potential Analysis, By Region

6.2 Market Positioning Analysis of Key Players in Infectious Disease Diagnostics Market

6.2.1 Company Analysis

6.2.2 Growth Strategy Analysis

6.2.3 Performance of Key Players

6.2.3.1 F.Hoffmann-La Roche Ltd.

6.2.3.2 Abbott Laboratories

7. Global Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 By Product: Market Revenue and Forecast Analysis (US$ Million)

7.3 Kits and Reagents

7.3.1 Overview

7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)

8. Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology

8.1 Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

8.2 Immunodiagnostics

8.2.1 Overview

8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Polymerase Chain Reaction (PCR)

8.3.1 Overview

8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Next Generation Sequencing

8.4.1 Overview

8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Clinical Microbiology

8.5.1 Overview

8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type

9.1 Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

9.2 Laboratory Testing

9.2.1 Overview

9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Point of Care Testing

9.3.1 Overview

9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Global Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication

10.1 Overview

10.2 Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

10.3 HIV

10.3.1 Overview

10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4 Hepatitis

10.4.1 Overview

10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

10.5 Healthcare Associated Infections (HAIs)

10.5.1 Overview

10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

10.6 Human Papillomavirus (HPV)

10.6.1 Overview

10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

10.7 Tuberculosis (TB)

10.7.1 Overview

10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

10.8 Influenza

10.8.1 Overview

10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)

10.9 Others

10.9.1 Overview

10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. Infectious Disease Diagnostics Market Analysis – by End User

11.1 Overview

11.2 Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

11.3 Hospitals and Clinics

11.3.1 Overview

11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Pathology or Diagnostic Laboratories

11.4.1 Overview

11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Research Institutes

11.5.1 Overview

11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.6 Home Care Settings

11.6.1 Overview

11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.7 Others

11.7.1 Overview

11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12. Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Geographical Analysis

12.1 North America: Infectious Disease Diagnostics Market

12.1.1 Overview

12.1.2 North America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.5 North America: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.6 North America: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.1.8 North America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.1.8.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.2 US: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.8.1.6 US: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.1.8.2 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.1 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.2 Canada: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.1.8.3 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.1 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.2 Mexico: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.2 Europe: Infectious Disease Diagnostics Market

12.2.1 Overview

12.2.2 Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3 Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.5 Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.6 Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.7 Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8 Europe: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.2.8.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.2 Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.3 Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.4 Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.5 Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.6 Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.1 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.2 France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.3 France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.4 France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.5 France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.6 France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.1 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.2 UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.3 UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.4 UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.5 UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.6 UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.1 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.2 Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.1 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.2 Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.1 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.2 Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3 Asia Pacific: Infectious Disease Diagnostics Market

12.3.1 Overview

12.3.2 Asia Pacific: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8 Asia Pacific: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.3.8.1 China: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.1.1 China: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.1.2 China: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.3.8.1.6 China: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.2 Japan: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.2.1 Japan: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.2.2 Japan: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.3 India: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.3.1 India: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.3.2 India: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.3.3 India: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.3.4 India: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.3.5 India: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.3.6 India: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.4 Australia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.4.1 Australia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.4.2 Australia: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.4.3 Australia: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.4.4 Australia: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.4.5 Australia: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.4.6 Australia: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.5 South Korea: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.5.1 South Korea: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.5.2 South Korea: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.5.3 South Korea: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.5.4 South Korea: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.5.5 South Korea: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.5.6 South Korea: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.6.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.4 Middle East and Africa: Infectious Disease Diagnostics Market

12.4.1 Overview

12.4.2 Middle East & Africa: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

12.4.3 Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8 Middle East & Africa: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.4.8.1 Saudi Arabia: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.4.8.1.1 Saudi Arabia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.1.2 Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.1.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.1.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.1.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.1.6 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8.2 UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.2.1 UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.2.2 UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.2.3 UAE: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.2.4 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.2.5 UAE: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.2.6 UAE: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8.3 South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.3.1 South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.3.2 South Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.3.3 South Africa: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.3.4 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.3.5 South Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.3.6 South Africa: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8.4 Rest of Middle East and Africa: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.4.8.4.1 Rest of Middle East and Africa: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.4.8.4.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.4.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.4.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.4.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.4.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5 South and Central America Infectious Disease Diagnostics Market Revenue and Forecast To 2028

12.5.1 Overview

12.5.2 South and Central America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.3 South and Central America: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.4 South and Central America: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.5.5 South and Central America: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.5.6 South and Central America: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5.7 South and Central America: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.5.8 South and Central America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.5.8.1 Brazil: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.1.1 Brazil: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.1.2 Brazil: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market , by Technology, 2019–2028 (USD Million)

12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.5.8.2 Argentina: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.2.1 Argentina: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.2.2 Argentina: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.8.2.3 Argentina: Infectious Disease Diagnostics Market , by Technology, 2019–2028 (USD Million)

12.5.8.2.4 Argentina: Infectious Disease Diagnostics Market , by Testing Type, 2019–2028 (USD Million)

12.5.8.2.5 Argentina: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5.8.2.6 Argentina: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.5.8.3 Rest of South and Central America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.3.1 Rest of South and Central America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.3.2 Rest of South and Central America: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.8.3.3 Rest of South and Central America: Infectious Disease Diagnostics Market , by Technology, 2019–2028 (USD Million)

12.5.8.3.4 Rest of South and Central America: Infectious Disease Diagnostics Market , by Testing Type, 2019–2028 (USD Million)

12.5.8.3.5 Rest of South and Central America: Infectious Disease Diagnostics Market , by Disease Indication, 2019–2028 (USD Million)

12.5.8.3.6 Rest of South and Central America: Infectious Disease Diagnostics Market , by End User, 2019–2028 (USD Million)

13. Impact Of COVID-19 Pandemic on Infectious Disease Diagnostics Market

13.1 North America: Impact Assessment of COVID-19 Pandemic

13.2 Europe: Impact Assessment of COVID-19 Pandemic

13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Infectious Disease Diagnostics Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies in the Infectious Disease Diagnostics Market

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 Danaher

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 Abbott

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 BD

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 Trinity Biotech

15.4.1 1.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 F. HOFFMANN-LA ROCHE LTD.

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Cardinal Health Inc.

15.6.1 1.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 bioMerieux SA

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 BIO-RAD LABORATORIES INC.

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 AccuBioTech Co., Ltd.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

15.10 ACON Laboratories, Inc.

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Products and Services

15.10.4 Financial Overview

15.10.5 SWOT Analysis

15.10.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms in Infectious Disease Diagnostics Market

LIST OF TABLES

Table 1. Infectious Diseases and Funding

Table 2. North America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 4. North America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6. North America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 11. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 16. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23. Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 24. Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 26. Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27. Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 28. Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 29. Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 30. Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 31. Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 32. France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 33. France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 34. France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 35. France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 36. France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37. UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 38. UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 39. UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 40. UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 41. UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 42. Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 43. Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 44. Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 45. Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 46. Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 47. Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 48. Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 49. Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 50. Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 51. Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 55. Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 56. Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 57. Asia Pacific: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 58. Asia Pacific: Infectious Disease Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 59. Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type– Revenue and forecast to 2028 (USD Million)

Table 60. Asia Pacific: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and forecast to 2028 (USD Million)

Table 61. Asia Pacific: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 62. China: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 63. China: Infectious Disease Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 64. China: Infectious Disease Diagnostics Market, by Testing Type– Revenue and forecast to 2028 (USD Million)

Table 65. China: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and forecast to 2028 (USD Million)

Table 66. China: Infectious Disease Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 67. Japan: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 68. Japan: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 69. Japan: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 70. Japan: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 71. Japan: Infectious Disease Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 72. India: Infectious Disease Diagnostics Market, By Product– Revenue and Forecast to 2028 (USD Million)

Table 73. India: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 74. India: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 75. India: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 76. India: Infectious Disease Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 77. Australia: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 78. Australia: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 79. Australia: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 80. Australia: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 81. Australia: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 82. South Korea: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 83. South Korea: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 84. South Korea: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 85. South Korea: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 86. South Korea: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 87. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 88. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 89. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 90. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 91. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 92. Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 93. Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 94. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 95. Middle East & Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 96. Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 97. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 98. Saudi Arabia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 99. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 100. Saudi Arabia Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 101. Saudi Arabia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 102. UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 103. UAE Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 104. UAE Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 105. UAE Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 106. UAE Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 107. South Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 108. South Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 109. South Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 110. South Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 111. South Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 112. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 113. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 114. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 115. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 116. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 117. South and Central America: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 118. South and Central America: Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 119. South and Central America: Infectious Disease Diagnostics Market, by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 120. South and Central America: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 121. South and Central America: Infectious Disease Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 122. Brazil: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 123. Brazil: Infectious Disease Diagnostics Market , by Technology – Revenue and Forecast to 2028 (USD Million)

Table 124. Brazil: Infectious Disease Diagnostics Market, by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 125. Brazil: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 126. Brazil: Infectious Disease Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 127. Argentina: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 128. Argentina: Infectious Disease Diagnostics Market , by Technology – Revenue and Forecast to 2028 (USD Million)

Table 129. Argentina: Infectious Disease Diagnostics Market , by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 130. Argentina: Infectious Disease Diagnostics Market , by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 131. Argentina: Infectious Disease Diagnostics Market , by End User– Revenue and Forecast to 2028 (USD Million)

Table 132. Rest of South and Central America: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 133. Rest of South and Central America: Infectious Disease Diagnostics Market , by Technology – Revenue and Forecast to 2028 (USD Million)

Table 134. Rest of South and Central America: Infectious Disease Diagnostics Market , by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 135. Rest of South and Central America: Infectious Disease Diagnostics Market , by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 136. Rest of South and Central America: Infectious Disease Diagnostics Market , by End User– Revenue and Forecast to 2028 (USD Million)

Table 137. Organic Developments Done By Companies

Table 138. Inorganic Developments Done By Companies

Table 139. Glossary of Terms in Infectious Disease Diagnostics Market

LIST OF FIGURES

Figure 1. Infectious Disease Diagnostics Market Segmentation

Figure 2. Infectious Disease Diagnostics Market, By Region

Figure 3. Global Infectious Disease Diagnostics Market Overview

Figure 4. Kits and Reagents Segment Held Largest Share of Product Segment in Infectious Disease Diagnostics Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Infectious Disease Diagnostics Market, by Geography (US$ Million)

Figure 7. Global Infectious Disease Diagnostics Market - Leading Country Markets (US$ Million)

Figure 8. Global Infectious Disease Diagnostics Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East And Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Infectious Disease Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 16. Global Infectious Disease Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 17. Global Infectious Disease Diagnostics Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 18. Global Infectious Disease Diagnostics Market – Market Potential Analysis, By Region

Figure 19. Market Positioning Analysis of Key Players in Global Infectious Disease Diagnostics Market

Figure 20. Global Infectious Disease Diagnostics Market – Comparative Company Analysis

Figure 21. Global Infectious Disease Diagnostics Market – Growth Strategy Analysis

Figure 22. By Product: Market Analysis and Forecast 2021 and 2028 (%)

Figure 23. Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Instruments Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. Software and Services Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

Figure 27. Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

Figure 33. Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

Figure 36. HIV Market Revenue and Forecast to 2028 (US$ Million)

Figure 37. Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

Figure 38. Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

Figure 39. Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

Figure 40. Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

Figure 41. Influenza Market Revenue and Forecast to 2028 (US$ Million)

Figure 42. Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 43. Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

Figure 44. Hospitals: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. North America: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 50. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 51. North America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 52. US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 55. Europe: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 56. Europe: Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 57. Europe: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 58. Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60. UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61. Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 62. Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 63. Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64. Asia Pacific: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 65. Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 66. Asia Pacific: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 67. China: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 68. Japan: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 69. India: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 70. Australia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 71. South Korea: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 72. Rest of Asia Pacific: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 73. Middle East & Africa: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 74. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 75. Middle East & Africa: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 76. Saudi Arabia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 77. UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 78. South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 79. Rest of Middle East and Africa: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

Figure 80. South and Central America: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 81. South and Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 82. South and Central America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 83. Brazil: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 84. Argentina: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 85. Rest of South and Central America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 86. Impact of COVID-19 Pandemic in North American Country Markets

Figure 87. Impact of COVID-19 Pandemic in European Country Markets

Figure 88. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 89. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 90. Impact of COVID-19 Pandemic in South and Central America Country Markets

Figure 91. Growth Strategies in the Infectious Disease Diagnostics Market

The List of Companies - Infectious Disease Diagnostics Market

  1. Danaher
  2. Abbott
  3. BD
  4. Trinity Biotech
  5. F. HOFFMANN-LA ROCHE LTD.
  6. Cardinal Health Inc
  7. bioMerieux SA
  8. BIO-RAD LABORATORIES INC.
  9. AccuBioTech Co., Ltd.
  10. ACON Laboratories, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the infectious disease diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. 
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPHE100001430
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount